Chui Y. Mah

761 total citations
12 papers, 386 citations indexed

About

Chui Y. Mah is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chui Y. Mah has authored 12 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Chui Y. Mah's work include Cancer, Lipids, and Metabolism (8 papers), Prostate Cancer Treatment and Research (7 papers) and Ferroptosis and cancer prognosis (2 papers). Chui Y. Mah is often cited by papers focused on Cancer, Lipids, and Metabolism (8 papers), Prostate Cancer Treatment and Research (7 papers) and Ferroptosis and cancer prognosis (2 papers). Chui Y. Mah collaborates with scholars based in Australia, Belgium and United States. Chui Y. Mah's co-authors include Lisa M. Butler, Zeyad D. Nassar, Andrew J. Hoy, Johannes V. Swinnen, David J. Lynn, Luke A. Selth, Swati Irani, Jonas Dehairs, Margaret M. Centenera and Max Moldovan and has published in prestigious journals such as Cancer Research, British Journal of Cancer and eLife.

In The Last Decade

Chui Y. Mah

12 papers receiving 384 citations

Peers

Chui Y. Mah
Shuoyi Ma China
C. G. Wood United States
Ningning Kang China
Hangchuan Shi United States
Shintaro Ide Japan
Fei Huo China
Yi Xue China
Yuxia Zhao China
Shuoyi Ma China
Chui Y. Mah
Citations per year, relative to Chui Y. Mah Chui Y. Mah (= 1×) peers Shuoyi Ma

Countries citing papers authored by Chui Y. Mah

Since Specialization
Citations

This map shows the geographic impact of Chui Y. Mah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chui Y. Mah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chui Y. Mah more than expected).

Fields of papers citing papers by Chui Y. Mah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chui Y. Mah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chui Y. Mah. The network helps show where Chui Y. Mah may publish in the future.

Co-authorship network of co-authors of Chui Y. Mah

This figure shows the co-authorship network connecting the top 25 collaborators of Chui Y. Mah. A scholar is included among the top collaborators of Chui Y. Mah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chui Y. Mah. Chui Y. Mah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shrestha, Raj K., Zeyad D. Nassar, Adrienne R. Hanson, et al.. (2024). ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis. Cancer Research. 84(14). 2313–2332. 18 indexed citations
2.
Mah, Chui Y., Jonas Dehairs, Feargal J. Ryan, et al.. (2024). Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer. British Journal of Cancer. 130(5). 741–754. 14 indexed citations
3.
Gillis, Joanna L., Chui Y. Mah, Swati Irani, et al.. (2023). Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. British Journal of Cancer. 129(8). 1350–1361. 7 indexed citations
4.
Martin, Sally K., Peck Yin Chin, James Breen, et al.. (2021). The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin. Bone Research. 9(1). 10–10. 10 indexed citations
5.
Schjenken, John E., et al.. (2021). Endocrine Disruptor Compounds—A Cause of Impaired Immune Tolerance Driving Inflammatory Disorders of Pregnancy?. Frontiers in Endocrinology. 12. 607539–607539. 49 indexed citations
6.
Nassar, Zeyad D., Chui Y. Mah, Margaret M. Centenera, et al.. (2020). Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition. Molecular Cancer Research. 18(10). 1500–1511. 19 indexed citations
7.
Nassar, Zeyad D., Chui Y. Mah, Jonas Dehairs, et al.. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. eLife. 9. 140 indexed citations
8.
Roscioli, Eugene, et al.. (2020). LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness. Frontiers in Oncology. 10. 1298–1298. 35 indexed citations
9.
Shrestha, Raj K., Scott L. Townley, Adrienne R. Hanson, et al.. (2020). Abstract PO-036: ACSM1 and ACSM3 regulate fatty acid oxidation in prostate cancer to promote growth and protect against oxidative stress. Cancer Research. 80(23_Supplement). PO–36. 2 indexed citations
10.
Mah, Chui Y., Zeyad D. Nassar, Johannes V. Swinnen, & Lisa M. Butler. (2019). Lipogenic effects of androgen signaling in normal and malignant prostate. Asian journal of urology. 7(3). 258–270. 33 indexed citations
11.
Nassar, Zeyad D., Margaret M. Centenera, Jelle Machiels, et al.. (2019). Lipid elongation in prostate cancer: an androgen regulated process and a novel therapeutic target. 1 indexed citations
12.
Nassar, Zeyad D., et al.. (2018). Peri‐prostatic adipose tissue: the metabolic microenvironment of prostate cancer. British Journal of Urology. 121(S3). 9–21. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuoyi Ma Breakdown of academic impact, for papers by C. G. Wood Breakdown of academic impact, for papers by Ningning Kang Breakdown of academic impact, for papers by Hangchuan Shi Breakdown of academic impact, for papers by Shintaro Ide Breakdown of academic impact, for papers by Fei Huo Breakdown of academic impact, for papers by Yi Xue Breakdown of academic impact, for papers by Yuxia Zhao
Rankless by CCL
2026